86 related articles for article (PubMed ID: 3029252)
21. [Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis].
Nishioka Y; Kitada O; Meguro T; Aragane K; Tanimukai T; Nakamura H; Nakahama H; Matsuyama T; Sugita M; Yano T; Takenaka Y; Takamitsu Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):527-30. PubMed ID: 10097751
[TBL] [Abstract][Full Text] [Related]
22. [The protective effect of medroxyprogesterone acetate in patients with ovarian cancer treated with chemotherapy].
Enzelsberger H; Sevelda P; Salzer H
Gynakol Rundsch; 1988; 28 Suppl 2():195-7. PubMed ID: 2976722
[No Abstract] [Full Text] [Related]
23. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
[No Abstract] [Full Text] [Related]
24. [A clinical trial Furlutal in the prevention of anorexia, weight loss and myelosuppression due to chemotherapy].
Wang J; Zhang P; Wang H
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):283-5. PubMed ID: 7587896
[TBL] [Abstract][Full Text] [Related]
25. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
[No Abstract] [Full Text] [Related]
26. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Saito R; Tsuchiya S; Minato K; Ishizuka T
Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
[No Abstract] [Full Text] [Related]
27. Increased myelotoxicity of idarubicin: is there a pharmacological basis? Results of a pharmacokinetic and an in vitro cytotoxicity study.
Kroschinsky F; Schleyer E; Renner U; Schimming C; Schimmelpfennig C; Bornhäuser M; Illmer T; Trümper L; Ehninger G; Schaich M
Cancer Chemother Pharmacol; 2004 Jan; 53(1):61-7. PubMed ID: 12955471
[TBL] [Abstract][Full Text] [Related]
28. [Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies].
Wu DP; Tang XW; Sun AN; Qiu HY; Fu ZZ; Ma R; Ruan CG
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):599-601. PubMed ID: 14690573
[TBL] [Abstract][Full Text] [Related]
29. [Effect of chemotherapy on hematopoietic stem cells in peripheral blood].
Nieto MJ; Cañizo C; Corral M; Almeida J; San Miguel J
Sangre (Barc); 1996 Feb; 41(1):29-35. PubMed ID: 8779031
[TBL] [Abstract][Full Text] [Related]
30. [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
Petrova IV; Stepovaia EA; Sokolova IB; Gol'dberg VE; Chasovskikh NIu; Koreshkova KG; Bazhenova NG; Kolosova MV; Baskakov MB; Novitskiĭ VV; Medvedev MA
Biull Eksp Biol Med; 1997 Aug; 124(8):195-8. PubMed ID: 9410209
[No Abstract] [Full Text] [Related]
31. Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Herbrecht R; Damonte JC; Dufour P; Maloisel F; Liu KL; Ortiz S; Bergerat JP; Oberling F
Semin Oncol; 1992 Feb; 19(1 Suppl 1):7-10. PubMed ID: 1384135
[TBL] [Abstract][Full Text] [Related]
32. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
33. In vitro hematopoiesis following induction chemotherapy for acute leukemia.
Beyer GS; Bruno E; Hoffman R
Cancer Res; 1985 Nov; 45(11 Pt 2):5921-5. PubMed ID: 4053063
[TBL] [Abstract][Full Text] [Related]
34. [Vepeside (VP-16-213) in the treatment of bronchopulmonary cancer (preliminary data)].
Anastasatu C; Burnea D; Iancovici O; Avramescu D; Burnea-Cornetti R
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(1):41-56. PubMed ID: 3033800
[No Abstract] [Full Text] [Related]
35. Autologous bone marrow transplantation in neoplasia.
Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
[No Abstract] [Full Text] [Related]
36. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
Yanagawa H; Bando H; Takishita Y
Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
[TBL] [Abstract][Full Text] [Related]
37. [A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
Matsuura Y; Nakamura H; Kogure K; Fukazawa M; Okuyama Y; Kawano E; Ishii A; Nishimura M; Hashimoto S; Oh H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):237-41. PubMed ID: 8311495
[TBL] [Abstract][Full Text] [Related]
38. [Polychemotherapy of small-cell bronchopulmonary cancer. The advantages of adding the selective cytostatic Riaval].
Păunescu E; Dănălache-Dumitrescu M; Oprişiu G; Smărăndache M; Stoinescu M; Vasile DI; Zaharescu C; Burnea D; Claiciu I; Ghinescu V
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):233-42. PubMed ID: 3027860
[No Abstract] [Full Text] [Related]
39. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Robak T; Krykowski E; Warzocha K
Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):331-7. PubMed ID: 1340191
[TBL] [Abstract][Full Text] [Related]
40. [Dicarbamine as a hemoprotective agent in patients with hemoblastoses treated with chemotherapy].
Ivanova OV
Vopr Onkol; 2012; 58(3):416-9. PubMed ID: 22888661
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
